FedEx Newsroom

FedEx Newsroom

FedEx Participates at 23rd INTERPHEX JAPAN Conference

July 1, 2010

Taipei, July 1, 2010 – FedEx Express (FedEx), a subsidiary of FedEx Corp. NYSE: FDX) and the world’s largest express transportation company, will participate for the first time at the 23rd INTERPHEX JAPAN conference, Asia’s largest pharmaceutical event, from June 30 to July 2.
        At the event, FedEx will highlight its latest capabilities, including a range of temperature-controlled cargo containers and packaging solutions for healthcare and pharmaceutical customers, as part of its FedEx HealthCare Solutions™ suite of services[1]. A dedicated team in Japan has been formed to support the specialized needs of the healthcare industry and temperature-controlled airfreight services.
        "FedEx HealthCare Solutions™ is another way FedEx responds to the specialized needs of our customers, which features FedEx trademark quality service and reliability with industry-specific considerations," said David L. Cunningham, Jr., president, Asia Pacific, FedEx Express. “Japan’s US$90.3 billion pharmaceutical market is the second largest in the world[2]. It grew 7.6% in 2009 and is forecast to grow between 2 – 5% by 2014[3]. Hence, it is important for us to be present at INTERPHEX JAPAN to showcase our advanced temperature controlled airfreight solutions to customers in the healthcare sector.”
 
Features of FedEx Temperature-Controlled Solutions
·           Time-definite express delivery service
·           Door-to-door delivery service
·           Specialized temperature-controlled packaging solutions
·           Continuous monitoring of shipment temperatures in-transit
·           FedEx dedicated freighter aircraft operations
 
Visit the FedEx booth at INTERPHEX JAPAN: LOGISITICS 2010, East Hall, 48-25.
 
(US input: Any info of similar service/innovation in our global network?)


[1] “FedEx HealthCare Solutions” is a trademark of Federal Express Corporation.
[2] IMS Health Market Prognosis, March 2010.
[3] IMS Health Market Prognosis, March 2010.
 

You may also like: